WELL Health Technologies Corp.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- WELL Health Technologies Corp. (TSX: WELL) operates as a practitioner-focused digital healthcare company, owning and operating the largest network of outpatient clinics in Canada focused on primary, allied, diagnostic, specialized, and preventative care services; providing omni-channel patient services in the United States including national telehealth, brick-and-mortar clinics, and anesthesia services across 19 states; and offering a comprehensive practitioner enablement platform with electronic medical records (EMR) systems such as OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD); telehealth platforms; practice management software; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions; cybersecurity protection and patient data privacy tools; ePharma; digital booking; e-Referral; and e-Rx services. The company serves medical clinics, healthcare practitioners, and public sector healthcare systems in Canada, the United States, and internationally, targeting markets such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. Founded in 2010 and headquartered in Vancouver, British Columbia, Canada, WELL Health Technologies continues to expand through strategic acquisitions and partnerships. Recent developments include the addition of $100 million in annualized revenue from seven acquisitions since December 2024, paid in cash; launches under the WELLSTAR division for advanced digital solutions; the acquisition of Harmony to enhance anesthesia staffing via CRH Medical; two clinic acquisitions in British Columbia in July 2025 adding over $12 million in annual revenue; and a 50/50 clinical research joint venture with HEALWELL AI established in November 2025 incorporating Bio Pharma Services.
Company News
WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto
WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV
WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement
WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELL Health Redeems $70 Million 5.50% Convertible Debentures
WELL Health Technologies Q2 Earnings Call Highlights
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer
WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026
WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada’s Leading Healthcare Software and AI Platforms
WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada's Leading Healthcare Software and AI Platforms
WELL Health Announces Voting Results for Election of Directors
WELL Health Provides a Corporate Update on Circle Medical
WELL Health Strengthens Clinical and Public Sector Leadership with Appointment of Dr. Andrew Bond as Chief Health Officer and Head of Public Sector